Last updated on June 2019

Ceftobiprole in the Treatment of Pediatric Patients With Pneumonia


Brief description of study

This is a study of the safety and efficacy of ceftobiprole in pediatric patients with hospital-acquired bacterial pneumonia (HAP) or community-acquired bacterial pneumonia (CAP) requiring hospitalization.

Detailed Study Description

This is a randomized, investigator-blind, active-controlled study to evaluate the safety, tolerability, pharmacokinetics and efficacy of ceftobiprole versus intravenous standard-of-care cephalosporin treatment with or without vancomycin in pediatric patients aged from 3 months to less than 18 years with HAP or CAP requiring hospitalization.

Clinical Study Identifier: NCT03439124

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.